Glucagon-like peptide 1 (GLP-1) receptor agonist drugs have been on the forefront as a promising treatment for multiple health issues -- specifically in the management of type 2 diabetes and weight management. Vanderbilt Health has opened..
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.